Manufacturing / Pharmaceutical Preparations
Summit Therapeutics Inc.
SMMT
$15.48
-$0.08 (-0.51%)
Price as of Oct 24, 2026 02:11 UTC
14 B
Market Cap (Large Cap)
39%
IV Rank
106.9%
Implied Volatility
Nov 11
Next Earnings
Technical Signals
as of Oct 21
Bearish
0 of 7
Trend
- Above 20-day average $16.17
- Above 50-day average $15.95
- Above 200-day average $16.47 · -3.9%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 31d ago
Volume
- Below-average volume 0.8x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.20
Bullish skew
Implied Volatility
106.9%
1% percentile
IV vs Realized
Options rich
30d HV 59.0%
Options Heat Map
Delta-risk grid for SMMT options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
13 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | DUGGAN ROBERT W | Buy | 3,810,000 | $49,987,200 | +17.9% | |
| Jun 12, 2026 | Zanganeh Mahkam | Buy | 3,810,000 | $49,987,200 | +17.9% | |
| Jun 04, 2026 | Soni Manmeet Singh | Buy | 25,000 | $360,750 | +7.2% | |
| Jun 04, 2026 | Soni Manmeet Singh | Buy | 25,000 | $361,500 | +7.0% | |
| Jun 04, 2026 | Zanganeh Mahkam | Buy | 100,000 | $1,460,000 | +6.0% | |
| Jun 04, 2026 | DUGGAN ROBERT W | Buy | 100,000 | $1,460,000 | +6.0% | |
| Jan 08, 2026 | Anand Bhaskar | Grant | 30,000 | $0 | -17.8% | |
| Jan 02, 2026 | Clark Kenneth A | Grant | 35,000 | $0 | -11.7% | |
| Jan 02, 2026 | Huber Jeff | Grant | 9,885 | $86,593 | +76.6% | |
| Jan 02, 2026 | DUGGAN ROBERT W | Grant | 11,232 | $98,392 | +76.6% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Oct 19, 2026 | Q3 2026 | -$0.30 |
Track SMMT with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SMMT and your entire portfolio.